𝔖 Bobbio Scriptorium

✦ LIBER ✦

Comparison of the safety and efficacy of enoxaparin with unfractionated heparin and phenprocoumon as anticoagulation in cardioversion of nonvalvular atrial fibrillation

✍ Scribed by Uwe Nixdorff; Christoph Stellbrink; Thomas Hofmann; Peter Hanrath; Walter Lehmacher; Andre Schmidt-Lucke

Book ID: 119546505
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 192 KB
Volume: 41
Category: Article
ISSN: 1558-3597
DOI: 10.1016/s0735-1097(03)80980-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and efficacy of enoxaparin compar

Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) Trial

✍ C Stellbrink; U Nixdorff; T Hofmann 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Safety and Efficacy of Enoxaparin Compar

Safety and Efficacy of Enoxaparin Compared With Unfractionated Heparin and Oral Anticoagulants for Prevention of Thromboembolic Complications in Cardioversion of Nonvalvular Atrial Fibrillation: The Anticoagulation in Cardioversion using Enoxaparin (ACE) Trial

✍ Stellbrink, C. 📂 Article 📅 2004 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 164 KB

Comparison of Anticoagulant and Anti-Inf

Comparison of Anticoagulant and Anti-Inflammatory Responses Using Enoxaparin Versus Unfractionated Heparin for Transesophageal Echocardiography-Guided Cardioversion of Atrial Fibrillation

✍ Debra Hoppensteadt; Jawed Fareed; Allan L. Klein; Susan E. Jasper; Carolyn Apper 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 289 KB

Quality of anticoagulation with unfracti

Quality of anticoagulation with unfractionated heparin plus phenprocoumon for the prevention of thromboembolic complications in cardioversion for non-valvular atrial fibrillation. Sub-analysis from the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial

✍ Caroline Schmidt-Lucke; W. Dieter Paar; Christoph Stellbrink; Uwe Nixdorff; Thom 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 128 KB

Trial finds that enoxaparin may be the p

Trial finds that enoxaparin may be the preferred drug for initiating anticoagulation in atrial fibrillation: Abstracted from: Stellbrink C, Nixdorff U, Hofmann T, et al. Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: The Anticoagulation in Cardioversion using Enoxaparin (ACE) Trial. Circulation 2004; 109: 997-1003.

📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 126 KB

Use of Subcutaneous Enoxaparin Compared

Use of Subcutaneous Enoxaparin Compared to Intravenous Heparin and Oral Phenprocoumon in the Setting of Cardioversion—The ACE Study (Anticoagulation in Cardioversion Using Enoxaparin)

✍ Christoph Stellbrink; Uwe Nixdorff; Thomas Hofmann; Walter Lehmacher; WernerGünt 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 71 KB